Is UCB PHARMA still active?

Yes, UCB PHARMA is currently active.

Where is UCB PHARMA registered?

UCB PHARMA's registered address is Allée de la Recherche 60, 1070 Anderlecht, Belgium.

How many employees does UCB PHARMA have?

Based on its most recently filed annual accounts (fiscal year ending 31 Dec 2025), UCB PHARMA reported 1,960.6 full-time equivalent employees.

What is UCB PHARMA's annual turnover?

UCB PHARMA's most recently filed annual turnover (fiscal year ending 31 Dec 2025) was €4,622,639,386.

Did UCB PHARMA make a profit or a loss?

UCB PHARMA's most recently filed annual accounts (fiscal year ending 31 Dec 2025) reported a profit of €4,239,651,764.

When did UCB PHARMA last file annual accounts?

UCB PHARMA's most recently filed annual accounts cover the fiscal year ending 31 Dec 2025.

Is UCB PHARMA B Corp certified?

We have no B Corp certification on file for UCB PHARMA.

Does UCB PHARMA hold Fairtrade certification?

No, UCB PHARMA does not currently hold Fairtrade certification.

UCB PHARMA

Q: When was UCB PHARMA founded?

UCB PHARMA was founded on 01 Feb 1968, making it 58 years old.

Q: What does UCB PHARMA do?

UCB PHARMA's registered main activities are Manufacture of medicaments, Wholesale of pharmaceutical and medical goods, Research and experimental development on other natural sciences and engineering, and Study, development of the production of active ingredients for drug manufacturing.

BE 0403.096.168

Copied!

NV/SA

Status

Active

Founded

01 Feb 1968

Size

Large · 1,960.6 FTE

Age

58 yrs

Main activity

Manufacture of medicaments

Activities

4 activities

Manufacture of medicamentsWholesale of pharmaceutical and medical goodsResearch and experimental development on other natural sciences and engineeringStudy, development of the production of active ingredients for drug manufacturing

Financials

CSRD-obligated

Turnover2025

€4.6B+9.8%

Profit / Loss2025

€4.2B+347.5%

Equity2025

€16.2B+31%

2025	2024	2023	2022
€4,622,639,386+9.8%	€4,211,459,762+32.6%	€3,177,016,793-3.6%	€3,295,211,826
€4,239,651,764+347.5%	€947,428,300+1%	€938,115,520-1%	€948,100,009
€16,234,819,937+31%	€12,395,168,174+5.1%	€11,797,739,873+5.3%	€11,209,624,353
€4,371,077,190+11.2%	€3,932,063,198+17.9%	€3,336,348,470+0.5%	€3,320,620,353
€7,874,572-28.8%	€11,059,144+43.9%	€7,687,095-54.4%	€16,847,177
1,960.6+12.3%	1,746.4+19.3%	1,464.4+6.8%	1,371.1
€2,357,768-2.2%	€2,411,509+11.2%	€2,169,501-9.7%	€2,403,334

Frequently asked questions

01What is UCB PHARMA's official registered name?

UCB PHARMA.

02What is UCB PHARMA's enterprise number (VAT number)?

BE 0403.096.168.

03What is UCB PHARMA's legal form?

Naamloze vennootschap (NV) / Société anonyme (SA).

04When was UCB PHARMA founded?

Sources

KBO — Kruispuntbank van Ondernemingen

NBB — Nationale Bank van België

Links

Belgian National Gazette — Publications

Check withholding obligation

Central Register of Director Disqualifications

	2025	2024	2023	2022
Income statement
	€4,622,639,386+9.8%	€4,211,459,762+32.6%	€3,177,016,793-3.6%	€3,295,211,826
	€291,343,444+16.7%	€249,704,424+19.7%	€208,623,064+10.6%	€188,569,160
	€334,670,083-67.4%	€1,027,458,416+17.7%	€872,812,729-11.4%	€985,684,580
	€426,454,959-60.8%	€1,088,652,075+21.3%	€897,798,129-21.2%	€1,139,452,692
	€4,356,114,570+321.7%	€1,033,081,060+7%	€965,213,600-11.6%	€1,091,920,125
	€4,239,651,764+347.5%	€947,428,300+1%	€938,115,520-1%	€948,100,009
	€30,491,539-54%	€66,223,522+558.9%	€10,050,881+62.5%	€6,186,285
Profitability
	9.2%-64.3%	25.8%-8.5%	28.3%-18.3%	34.6%
	91.7%+307.7%	22.5%-23.8%	29.5%+2.6%	28.8%
	26.1%+241.7%	7.6%-3.9%	8.0%-6%	8.5%
	20.4%+254.1%	5.8%-6.5%	6.2%-5.1%	6.5%
Solvency
	€20,742,385,083+26.4%	€16,414,794,946+8%	€15,197,496,330+4.3%	€14,568,296,839
	€1,075,264,999+10.2%	€975,353,777+12.2%	€869,136,326+17.1%	€742,008,378
	€16,025,398,122+31.3%	€12,202,619,330+5.5%	€11,564,576,024-1%	€11,685,962,981
	€16,234,819,937+31%	€12,395,168,174+5.1%	€11,797,739,873+5.3%	€11,209,624,353
	78.3%+3.7%	75.5%-2.7%	77.6%+0.9%	76.9%
	€2,085,984,545-1.3%	€2,113,463,674+1.2%	€2,087,660,683+0.6%	€2,076,262,923
	0.13-24.6%	0.17-3.6%	0.18-4.5%	0.19
	€4,371,077,190+11.2%	€3,932,063,198+17.9%	€3,336,348,470+0.5%	€3,320,620,353
	0.27-15.1%	0.32+12.2%	0.28-4.5%	0.30
	2.97-58.3%	7.14+5.6%	6.76-77.5%	30.05
Liquidity
	€7,874,572-28.8%	€11,059,144+43.9%	€7,687,095-54.4%	€16,847,177
	€1,153,698,655+6.4%	€1,084,547,748+32%	€821,359,178+20.2%	€683,490,682
	€1,367,717,967+15.3%	€1,186,239,719+22.8%	€966,240,843+10.2%	€876,583,061
	€1,742,403,711+78.2%	€977,816,973+72.3%	€567,452,507-21.4%	€721,663,366
	€2,265,106,332+27.3%	€1,779,243,837+47.2%	€1,208,879,575-0.3%	€1,212,711,565
	1.59-10.3%	1.77-19.4%	2.20+30.1%	1.69
	€1,348,248,044-4.3%	€1,409,384,808-6%	€1,500,201,128+72.1%	€871,528,634
Efficiency
	108 days+5%	103 days-7.4%	111 days+14.3%	97 days
	117 days+47.3%	79 days+29.7%	61 days-27.3%	84 days
	347 days+2.9%	337 days+9.7%	307 days-19.4%	381 days
	1.08-12.2%	1.23-5.4%	1.30+35.4%	0.96
Profit appropriation
	€400,000,000+14.3%	€350,000,0000%	€350,000,000+16.7%	€300,000,000
	€780,643,687+140.1%	€325,137,360+16.9%	€278,138,882+20.1%	€231,606,044
	€7,649,402,440+79.3%	€4,265,257,004+14.8%	€3,714,827,181+17.1%	€3,173,244,499

Sources

NBB — Nationale Bank van België

	2025	2024	2023	2022
Income statement
	€4,622,639,386+9.8%	€4,211,459,762+32.6%	€3,177,016,793-3.6%	€3,295,211,826
	€291,343,444+16.7%	€249,704,424+19.7%	€208,623,064+10.6%	€188,569,160
	€334,670,083-67.4%	€1,027,458,416+17.7%	€872,812,729-11.4%	€985,684,580
	€426,454,959-60.8%	€1,088,652,075+21.3%	€897,798,129-21.2%	€1,139,452,692
	€4,356,114,570+321.7%	€1,033,081,060+7%	€965,213,600-11.6%	€1,091,920,125
	€4,239,651,764+347.5%	€947,428,300+1%	€938,115,520-1%	€948,100,009
	€30,491,539-54%	€66,223,522+558.9%	€10,050,881+62.5%	€6,186,285
Profitability
	9.2%-64.3%	25.8%-8.5%	28.3%-18.3%	34.6%
	91.7%+307.7%	22.5%-23.8%	29.5%+2.6%	28.8%
	26.1%+241.7%	7.6%-3.9%	8.0%-6%	8.5%
	20.4%+254.1%	5.8%-6.5%	6.2%-5.1%	6.5%
Solvency
	€20,742,385,083+26.4%	€16,414,794,946+8%	€15,197,496,330+4.3%	€14,568,296,839
	€1,075,264,999+10.2%	€975,353,777+12.2%	€869,136,326+17.1%	€742,008,378
	€16,025,398,122+31.3%	€12,202,619,330+5.5%	€11,564,576,024-1%	€11,685,962,981
	€16,234,819,937+31%	€12,395,168,174+5.1%	€11,797,739,873+5.3%	€11,209,624,353
	78.3%+3.7%	75.5%-2.7%	77.6%+0.9%	76.9%
	€2,085,984,545-1.3%	€2,113,463,674+1.2%	€2,087,660,683+0.6%	€2,076,262,923
	0.13-24.6%	0.17-3.6%	0.18-4.5%	0.19
	€4,371,077,190+11.2%	€3,932,063,198+17.9%	€3,336,348,470+0.5%	€3,320,620,353
	0.27-15.1%	0.32+12.2%	0.28-4.5%	0.30
	2.97-58.3%	7.14+5.6%	6.76-77.5%	30.05
Liquidity
	€7,874,572-28.8%	€11,059,144+43.9%	€7,687,095-54.4%	€16,847,177
	€1,153,698,655+6.4%	€1,084,547,748+32%	€821,359,178+20.2%	€683,490,682
	€1,367,717,967+15.3%	€1,186,239,719+22.8%	€966,240,843+10.2%	€876,583,061
	€1,742,403,711+78.2%	€977,816,973+72.3%	€567,452,507-21.4%	€721,663,366
	€2,265,106,332+27.3%	€1,779,243,837+47.2%	€1,208,879,575-0.3%	€1,212,711,565
	1.59-10.3%	1.77-19.4%	2.20+30.1%	1.69
	€1,348,248,044-4.3%	€1,409,384,808-6%	€1,500,201,128+72.1%	€871,528,634
Efficiency
	108 days+5%	103 days-7.4%	111 days+14.3%	97 days
	117 days+47.3%	79 days+29.7%	61 days-27.3%	84 days
	347 days+2.9%	337 days+9.7%	307 days-19.4%	381 days
	1.08-12.2%	1.23-5.4%	1.30+35.4%	0.96
Profit appropriation
	€400,000,000+14.3%	€350,000,0000%	€350,000,000+16.7%	€300,000,000
	€780,643,687+140.1%	€325,137,360+16.9%	€278,138,882+20.1%	€231,606,044
	€7,649,402,440+79.3%	€4,265,257,004+14.8%	€3,714,827,181+17.1%	€3,173,244,499

2025

2024

2023

2022

Income statement

€4,622,639,386+9.8%

€4,211,459,762+32.6%

€3,177,016,793-3.6%

€3,295,211,826

€291,343,444+16.7%

€249,704,424+19.7%

€208,623,064+10.6%

€188,569,160

€334,670,083-67.4%

€1,027,458,416+17.7%

€872,812,729-11.4%

€985,684,580

€426,454,959-60.8%

€1,088,652,075+21.3%

€897,798,129-21.2%

€1,139,452,692

€4,356,114,570+321.7%

€1,033,081,060+7%

€965,213,600-11.6%

€1,091,920,125

€4,239,651,764+347.5%

€947,428,300+1%

€938,115,520-1%

€948,100,009

€30,491,539-54%

€66,223,522+558.9%

€10,050,881+62.5%

€6,186,285

Profitability

9.2%-64.3%

25.8%-8.5%

28.3%-18.3%

34.6%

91.7%+307.7%

22.5%-23.8%

29.5%+2.6%

28.8%

26.1%+241.7%

7.6%-3.9%

8.0%-6%

8.5%

20.4%+254.1%

5.8%-6.5%

6.2%-5.1%

6.5%

Solvency

€20,742,385,083+26.4%

€16,414,794,946+8%

€15,197,496,330+4.3%

€14,568,296,839

€1,075,264,999+10.2%

€975,353,777+12.2%

€869,136,326+17.1%

€742,008,378

€16,025,398,122+31.3%

€12,202,619,330+5.5%

€11,564,576,024-1%

€11,685,962,981

€16,234,819,937+31%

€12,395,168,174+5.1%

€11,797,739,873+5.3%

€11,209,624,353

78.3%+3.7%

75.5%-2.7%

77.6%+0.9%

76.9%

€2,085,984,545-1.3%

€2,113,463,674+1.2%

€2,087,660,683+0.6%

€2,076,262,923

0.13-24.6%

0.17-3.6%

0.18-4.5%

0.19

€4,371,077,190+11.2%

€3,932,063,198+17.9%

€3,336,348,470+0.5%

€3,320,620,353

0.27-15.1%

0.32+12.2%

0.28-4.5%

0.30

2.97-58.3%

7.14+5.6%

6.76-77.5%

30.05

Liquidity

€7,874,572-28.8%

€11,059,144+43.9%

€7,687,095-54.4%

€16,847,177

€1,153,698,655+6.4%

€1,084,547,748+32%

€821,359,178+20.2%

€683,490,682

€1,367,717,967+15.3%

€1,186,239,719+22.8%

€966,240,843+10.2%

€876,583,061

€1,742,403,711+78.2%

€977,816,973+72.3%

€567,452,507-21.4%

€721,663,366

€2,265,106,332+27.3%

€1,779,243,837+47.2%

€1,208,879,575-0.3%

€1,212,711,565

1.59-10.3%

1.77-19.4%

2.20+30.1%

1.69

€1,348,248,044-4.3%

€1,409,384,808-6%

€1,500,201,128+72.1%

€871,528,634

Efficiency

108 days+5%

103 days-7.4%

111 days+14.3%

97 days

117 days+47.3%

79 days+29.7%

61 days-27.3%

84 days

347 days+2.9%

337 days+9.7%

307 days-19.4%

381 days

1.08-12.2%

1.23-5.4%

1.30+35.4%

0.96

Profit appropriation

€400,000,000+14.3%

€350,000,0000%

€350,000,000+16.7%

€300,000,000

€780,643,687+140.1%

€325,137,360+16.9%

€278,138,882+20.1%

€231,606,044

€7,649,402,440+79.3%

€4,265,257,004+14.8%

€3,714,827,181+17.1%

€3,173,244,499

UCB PHARMA

Activities

Financials

Frequently asked questions

All locations

All locations